Q: Do you still consider Calian a hold after their Q1 report and MDA deal?
5i Research Answer:
We do still consider CGY a hold. EPS beat estimates of 99c coming in at $1.01 for the quarter. Revenue also beat estimates of $169.67M coming in at $179.18 displaying 21% year-over-year growth. We think there is some positive momentum with CGY as that is now back to back quarters of beating revenue and EPS estimates. CGY's commentary on the MDA acquisition was positive stating that it will "Strengthens its nuclear capability."